The Limits of Disclosure and the Power of the Outside Option: A Case for External Reference Pricing in Healthcare
By DAVID INTROCASO & ADAM CUNNINGHAM For over a decade, federal healthcare policy has operated…
By DAVID INTROCASO & ADAM CUNNINGHAM For over a decade, federal healthcare policy has operated on a foundational premise: if hospital prices are made visible, market discipline will inevitably follow. The push for price transparency—exemplified by federal disclosure rules and current legislative proposals such as the Lower Costs, More Transparency Act (H.R. 9393) and the…
Lakshmi Halasyamani, chief clinical officer at Endeavor Health, thinks value-based care isn’t really about payment models. To her, this work centers on understanding patients’ clinical, social and financial circumstances well enough to make care plans that actually work for their lives. The post Why Endeavor Health Refuses to Silo Its Value-Based Care Strategy appeared first…
Argenx’s first acquisition is the buyout of Forte Biosciences, a company with a lead drug that has early clinical validation in celiac disease and vitiligo. Argenx executives say this antibody complements its blockbuster product Vyvgart, offering a different mechanism of action but similar pipeline-in-a-product potential. The post Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook…
This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2025, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID,…
Donor government funding to combat HIV in low- and middle-income countries fell by $2.1 billion in 2025, a 25% decrease from the previous year, according to a new report by KFF and the Joint United Nations Programme on HIV/AIDS (UNAIDS). Total disbursements dropped to $6.2 billion in 2025, down from $8.
When staff are overextended and patients face delays or abandon care, the issue is no longer a narrow administrative burden. It becomes a business, financial, and access challenge that demands a different operating model. The post Prior Authorization Is Draining Revenue: Why Automation Has Become a Strategic Imperative appeared first on MedCity News.
The question is not whether the technology is impressive. The question is whether it shows up at the right time, with the right information, inside the workflow where the decision is being made. Anything else is just another report. The post How AI Inside Clinical Workflows Is Unlocking Patient Throughput appeared first on MedCity News.
[Sponsored] On a recent webinar sponsored by Verato, panelists from SCAN Health Group and the Alliance of Community Health Plans discussed how their organizations are meeting the moment. The post AI Readiness Starts with Solving Healthcare’s Data Fragmentation Problem appeared first on MedCity News.
As patients increasingly bring AI chatbot advice into exam rooms, where does liability land when that advice goes wrong? Health law attorney Meghan O’Connor said the answer still isn’t clear, but silence is the riskiest response for providers. The post What Happens When Patients Trust AI Over Their Doctor? appeared first on MedCity News.
A tiny federal agency tasked with protecting the public from injuries caused by lawn mowers and coffeemakers is demanding that some of the nation’s biggest health systems turn over detailed, personally identifiable medical records of all patients who seek help at their emergency rooms. The Consumer Product Safety Commission, responsible for tracking and issuing recalls…